Cytos
1 known investors
Kuros Biosciences develops biologic bone graft technologies, including its MagnetOs product, to support bone healing for surgeons and patients in spine, extremities, trauma, and oncology applications. The company is a Swiss-headquartered global company with commercial and research operations across more than 20 markets.
Investors · 1
Frequently asked questions
- What does Cytos do?
- Kuros Biosciences develops biologic bone graft technologies, including its MagnetOs product, to support bone healing for surgeons and patients in spine, extremities, trauma, and oncology applications. The company is a Swiss-headquartered global company with commercial and research operations across more than 20 markets.
- Who are Cytos's investors?
- Cytos's investors include Aisling Capital.